NASDAQ:SAIC • US8086251076
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SCIENCE APPLICATIONS INTE (SAIC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-12 | Goldman Sachs | Maintains | Sell -> Sell |
| 2026-01-13 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-12 | Citigroup | Initiate | Buy |
| 2025-12-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-05 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-09-10 | Jefferies | Maintains | Hold -> Hold |
| 2025-09-08 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-09-08 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-09-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-09-05 | Stifel | Maintains | Buy -> Buy |
| 2025-07-24 | Truist Securities | Maintains | Hold -> Hold |
| 2025-06-24 | Stifel | Reiterate | Buy |
| 2025-06-09 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-04 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-06-03 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-03 | Truist Securities | Maintains | Hold -> Hold |
| 2025-05-15 | Jefferies | Maintains | Hold -> Hold |
| 2025-04-15 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-18 | UBS | Maintains | Neutral -> Neutral |
| 2025-03-18 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-02-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-01-08 | TD Cowen | Downgrade | Buy -> Hold |
| 2025-01-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.704B 4.19% | 7.444B -3.37% | 7.479B 0.47% | 7.435B -0.59% | 7.523B 1.18% | 7.674B 2.01% | 8.182B 6.62% | |
| EBITDA YoY % growth | 689M 0.58% | 667M -3.19% | 711M 6.60% | 711.35M 0.05% | 734.06M 3.19% | 748.03M 1.90% | N/A | |
| EBIT YoY % growth | 532M 2.31% | 525M -1.32% | 571M 8.76% | 540.96M -5.26% | 600.39M 10.99% | 649.66M 8.21% | N/A | |
| Operating Margin | 6.91% | 7.05% | 7.63% | 7.28% | 7.98% | 8.47% | N/A | |
| EPS YoY % growth | 7.57 4.27% | 7.89 4.23% | 9.15 15.97% | 10.20 11.49% | 9.75 -4.46% | 10.73 10.09% | 12.34 15.02% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.93 -24.87% | 2.29 19.09% | 2.33 -35.72% | 2.61 0.97% | 2.58 33.65% | 2.74 20.00% | 2.69 15.41% | 3.13 20.20% | 3.08 19.37% |
| Revenue Q2Q % growth | 1.798B -2.18% | 1.903B 1.39% | 1.841B 4.07% | 1.955B 4.77% | 1.851B 2.95% | 1.941B 2.00% | 1.883B 2.28% | 2.034B 4.04% | 1.931B 4.32% |
| EBITDA Q2Q % growth | 174.4M -38.16% | 177.87M 11.17% | 179.93M -14.32% | 192.91M -18.60% | 185.3M 6.25% | 188.7M 6.09% | 183.33M 1.89% | 204.6M 6.06% | 196.87M 6.24% |
| EBIT Q2Q % growth | 145.84M 2.70% | 151.86M 22.47% | 152.95M 10.04% | 165.73M 29.48% | 147.18M 0.92% | 155.7M 2.53% | 151.32M -1.07% | 170.03M 2.59% | 164.05M 11.46% |
All data in USD
16 analysts have analysed SAIC and the average price target is 121.19 USD. This implies a price increase of 29.89% is expected in the next year compared to the current price of 93.3.
SCIENCE APPLICATIONS INTE (SAIC) will report earnings on 2026-03-16, before the market open.
The consensus EPS estimate for the next earnings of SCIENCE APPLICATIONS INTE (SAIC) is 1.93 USD and the consensus revenue estimate is 1.80B USD.
The expected long term growth rate for SCIENCE APPLICATIONS INTE (SAIC) is 0.31%.